Voyager醫療 VYGR 深 滬
已收盤 09-20 16:00:00 美东时间
6.25
-0.070
-1.11%
華盛通- 最 高6.32
- 今 開6.32
- 成交量 186.10万股
- 最 低 6.07
- 昨 收 6.32
- 總市值 2.74亿
- 52周最高 11.72
- 市盈率 靜 2.11
- 換手率 4.24%
- 52周最低 5.97
- 委 比 21.24%
- 總股本 4390.05万
- 歷史最高 31.91
- 量 比 4.21
- 振 幅 3.96%
- 歷史最低 2.46
- 每 手 1
- 風險率 0.98%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Novartis licenses gene therapy component from Voyager
Voyager Therapeutics (NASDAQ:VYGR) announced Thursday that Novartis (NYSE:NVS) has agreed to license a gene therapy component called capsid generated from its TRACER capsid discovery platform as part ...
09-05 21:16
快讯 | voyager therapeutics宣布根据纳斯达克上市规则5635（C）（4）进行诱因授予。
Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635...
08-30 04:01
Buy Rating Affirmed: Voyager Therapeutics’ Advancements and Revenue Potential in CNS Gene Therapy
H.C. Wainwright analyst Patrick Trucchio has reiterated their bullish stance on...
08-20 18:47
Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR), Amgen (AMGN) and ACADIA Pharmaceuticals (ACAD)
Companies in the Healthcare sector have received a lot of coverage today as ana...
08-09 18:52
快讯 | Voyager Therapeutics股份有限公司：Wedbush将目标价从8美元下调至7美元。
Voyager Therapeutics Inc : Wedbush Cuts Target Price to $7 From $8
08-07 19:18
快讯 | voyager therapeutics : 截至6月30日，强劲的371百万美元现金头寸，预计可提供多个临床数据披露的通道，一直持续到2027年。
Voyager Therapeutics : Strong Cash Position of $371 Mln as of June 30, Expected...
08-07 04:22
快讯 | voyager therapeutics第二季度每股收益美元指数-0.18，IBES估计美元指数-0.41。
Voyager Therapeutics Q2 EPS USD -0.18 Vs. IBES Estimate USD -0.41
08-07 04:01
快讯 | voyager therapeutics第二季度合作营业收入2957.8万美元
Voyager Therapeutics Q2 Collaboration Revenue USD 29.578 Million
08-07 04:01
快讯 | voyager therapeutics报告2024年第二季度财务和营运业绩
Voyager Therapeutics Reports Second Quarter 2024 Financial and Operating Results
08-07 04:01
快讯 | voyager therapeutics第二季度净利润为-1014.1美元，远低于IBES的预估净利润-2370万美元。
Voyager Therapeutics Q2 Net Income USD -10.141 Million Vs. IBES Estimate USD -2...
08-07 04:01
